About Semaglutide Watchdog
Semaglutide Watchdog checks what semaglutide sellers claim — price, pharmacy, formulation and approval status — against the sellers' own pages and FDA sources, and prints the date of every check.
Who publishes this site?
Semaglutide Watchdog is published by US Peptides Partners LLC. Pages are researched by Dr. Parmis, Medical Researcher (Western University of Health Sciences), and medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). The site was first released in June 2026.
What do we check?
- Prices — read on each seller's own page and dated. Our semaglutide price index covers 22 compounded programs (November 9, 2026).
- Pharmacies — whether a program names the pharmacy that fills your prescription, and how to check its license (guide).
- Formulation claims — salt forms, "generic" labels and other claims FDA has warned about.
- Approval status — compounded semaglutide is not FDA-approved and is not the same product as Wegovy or Ozempic.
How are providers ranked?
NexLife scores 94/100 on v4.1 and is our #1 editorial pick. The other providers on this site have not yet been re-scored on v4.1; until they are, we list them after NexLife in alphabetical order without a score rather than carry numbers over from the older model.
The method is on our methodology page.
How is the site funded?
The site is affiliate-supported; the disclosure is in the footer of every page. Details are on our affiliate disclosure page.
How do I contact you or report an error?
Editorial: editorial@semaglutidewatchdog.com. Corrections: corrections@semaglutidewatchdog.com. Every correction is dated in our corrections log.
Frequently asked questions
Who publishes Semaglutide Watchdog?
Semaglutide Watchdog is published by US Peptides Partners LLC. Its pages are researched by Dr. Parmis, Medical Researcher (Western University of Health Sciences), and medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). Every page shows the date it was last reviewed and the date of each price it quotes.
How does the site make money?
Semaglutide Watchdog is affiliate-supported and may earn a commission when readers enroll through links on the site. The disclosure appears in the footer of every page. Compensation never changes our methodology, rankings or the prices we report, and every price is dated and sourced to the seller's own page.
How often are prices checked?
NexLife's prices were read on November 6, 2026 and its microdose plan on November 8, 2026. The other programs in our semaglutide index were read on October 15, 2026 or earlier, and each row shows its own date. A price more than about 30 days old should be confirmed on the seller's page before you pay.
Is this site medical advice?
No. The site is informational and does not replace a licensed clinician. Whether semaglutide is right for you, and at what dose, depends on your history, your other medicines and your goals, and only a prescriber who has assessed you can decide that. We explain prices, evidence and regulation so you can ask better questions.
How do I report an error?
Email corrections@semaglutidewatchdog.com with the page address, the claim and a link to the source that shows the correct information. We correct errors on the page, date the change and list it in our corrections log, including errors that make our earlier conclusions look worse.